Sen. Angus King, I-Maine, introduced a bill Jan. 9 that prohibits direct-to-consumer (DTC) advertising of newly-approved prescription drugs for three years. The Responsibility in Drug Advertising Act (S.B. 3180) includes a waiver to allow DTC advertising for a drug whose widespread advertising is determined to have public health value.  “The widespread use of direct-to-consu... Read More